Even worse, the present study found that elevated Hsp90α/β protein levels, which are co-expressed with its client molecules and tumor drivers BRAF V600E mutated and Her2/neu overexpressed, further impaired the prognosis of CRC. This evidence concerns the gene HSP90AA1 and colorectal carcinoma.